What are the treatment options for endometriosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Endometriosis

The most effective treatment approach for endometriosis includes NSAIDs as first-line therapy, followed by hormonal treatments such as oral contraceptives or progestins, with surgery reserved for cases resistant to medical management. 1, 2

First-Line Management: NSAIDs

  • NSAIDs are recommended as the initial approach for immediate pain relief in patients with endometriosis pain 1, 2
  • Should be used at appropriate doses and schedules for optimal pain control 3
  • Effective for managing acute pain symptoms but often need to be combined with hormonal therapies for long-term management 4

Second-Line Management: Hormonal Therapies

Combined Oral Contraceptives (COCs)

  • Provide effective pain relief compared to placebo and may be equivalent to more costly regimens 1, 2
  • In network meta-analyses, COCs led to clinically significant pain reduction with mean differences between 13.15 and 17.6 points on a 0-100 visual analog scale 4
  • Considered first-line hormonal treatment for women not seeking immediate pregnancy 4

Progestins

  • Effective alternatives with similar efficacy to other hormonal treatments 1, 2
  • Options include:
    • Oral progestins (including dienogest, which has high specificity for progesterone receptors) 5
    • Depot medroxyprogesterone acetate (injectable) 1, 5
    • Levonorgestrel-releasing intrauterine system (LNG-IUS) 5, 6
  • Dydrogesterone can effectively treat endometriosis-associated pelvic pain without suppressing ovulation 5

GnRH Agonists and Antagonists

  • GnRH agonists for at least three months provide significant pain relief 1, 2
  • Appropriate for chronic pelvic pain, even without surgical confirmation of endometriosis 3, 1
  • When using GnRH agonists long-term, add-back therapy should be implemented to reduce bone mineral loss without reducing pain relief efficacy 3, 1, 2
  • Elagolix, an oral GnRH antagonist, is effective for managing moderate to severe endometriosis-associated pain 5

Third-Line Options

  • Aromatase inhibitors are used as second-line drugs for managing endometriosis-associated pelvic pain 5, 6
  • They prevent the conversion of steroid precursors to estrogens, both peripherally and at the ovarian level 5

Surgical Management

  • Surgery provides significant pain reduction during the first six months following the procedure 1, 2
  • For severe endometriosis, medical treatment alone may not be sufficient, and surgical intervention should be considered 2, 4
  • Surgical options include:
    • Laparoscopic removal of endometriotic lesions 4
    • Hysterectomy with surgical removal of lesions when initial treatments are ineffective 4
  • Important caveats:
    • Up to 44% of women experience symptom recurrence within one year after surgery 1, 2
    • Approximately 25% of patients who undergo hysterectomy for endometriosis experience recurrent pelvic pain 4
    • 10% undergo additional surgery, such as lysis of adhesions, to treat persistent pain 4

Complementary Approaches for Pain Management

  • Heat application to the abdomen or back may help reduce cramping pain 3, 2
  • Acupressure on specific points may help reduce pain 3, 2
  • Aromatherapy with lavender may increase satisfaction and reduce pain or anxiety 3, 2

Important Considerations and Pitfalls

  • Despite multiple treatment options, there is no medical therapy proven to completely eradicate endometriosis lesions 3, 2, 4
  • 11-19% of individuals with endometriosis have no pain reduction with hormonal medications 4
  • 25-34% experience recurrent pelvic pain within 12 months of discontinuing hormonal treatment 4
  • The pain associated with endometriosis has little relationship to the type of lesions seen by laparoscopy, but depth of lesions correlates with severity of pain 2
  • Diagnosis is often delayed, averaging 5-12 years after symptom onset, with most women consulting 3 or more clinicians prior to diagnosis 4
  • Hormone replacement therapy with estrogen is not contraindicated following hysterectomy and bilateral salpingo-oophorectomy for endometriosis 1

References

Guideline

Endometriosis Management Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pain Management for Endometriosis and Hemorrhagic Cysts

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment Options for Endometriosis Pain After Hysterectomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Endometriosis: A Review.

JAMA, 2025

Research

Recent Trends in Medical Management of Endometriosis.

Journal of obstetrics and gynaecology of India, 2024

Research

Hormonal drugs for the treatment of endometriosis.

Current opinion in pharmacology, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.